Actemra (tocilizumab)

Actemra (tocilizumab)

ACTEMRA is used to treat active moderate to severe rheumatoid arthritis (RA). ACTEMRA is also used to treat active systemic juvenile idiopathic arthritis (sJIA) and active moderate to severe polyarticular juvenile idiopathic arthritis (pJIA) in children over 2 years of age.

Patients
Consumer Medicine Information (CMI) - Infusion  Consumer Medicine Information (CMI) - Subcutaneous

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

MabThera (RA/GPA/MPA) (rituximab)

MabThera (RA/GPA/MPA) (rituximab)

MABTHERA is used to treat rheumatoid arthritis (RA), Granulomatosis with polyangiitis (Wegener's) (GPA) and Microscopic polyangiitis (MPA). 

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)